Two trials of AZD 7442 combination will enrol over 6,000 adults for the prevention of COVID-19 with additional trials enrolling approximately 4,000 adults for the treatment of SARS-CoV-2 infections.- AstraZeneca
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest